Product Information
FELBAMATE 400 MG TABLET is a generic product labeled by Viona Pharmaceuticals Inc., priced at $0.7124 per EA under NDC 72578005601. Its NADAC has been published 265 times since Jun 2, 2021.
Strength
400 mg/1
Manufacturer
Viona Pharmaceuticals Inc.NDC
72578005601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FELBAMATEApproval Type
Generic (ANDA)
FDA Application
ANDA208970On Market Since
3/3/2020
Pharmacological Classes
Price Statistics
The NADAC for FELBAMATE 400 MG TABLET has been published 265 times since Jun 2, 2021, and over the history we have for it it has declined 65.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7124 per EA |
|---|---|
| All-time high | $2.4593 (Aug 11, 2021) |
| All-time low | $0.7124 (Jun 17, 2026) |
| 52-week high | $1.0316 |
| 52-week low | $0.7124 |
| Median price | $1.0173 |
| Average price | $1.1465 |
| Largest weekly change | +55.2% (Aug 17, 2022) |
| Weeks tracked | 265 |
| Tracking since | Jun 2, 2021 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FELBAMATE 400 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FELBAMATE 400 MG TABLET, manufactured by Viona Pharmaceuticals Inc., is $0.7124 per EA (NDC 72578005601), effective Jun 24, 2026.
How has the price of FELBAMATE 400 MG TABLET changed over time?
Over the history we have for it, the NADAC for FELBAMATE 400 MG TABLET has declined 65.4%. It has been tracked across 265 weekly CMS publications since Jun 2, 2021.
What are the highest and lowest recorded NADAC prices for FELBAMATE 400 MG TABLET?
Since Jun 2, 2021, the NADAC for FELBAMATE 400 MG TABLET has ranged from a low of $0.7124 (Jun 17, 2026) to a high of $2.4593 (Aug 11, 2021), with a median of $1.0173 per EA.
Are there cheaper alternatives to FELBAMATE 400 MG TABLET?
5 NADAC-published products share the same active ingredient, strength, and dosage form as FELBAMATE 400 MG TABLET, but none are currently priced below it.
Who manufactures FELBAMATE 400 MG TABLET?
FELBAMATE 400 MG TABLET (NDC 72578005601) is labeled by Viona Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification